Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CB | NET |
|---|---|---|
| Price | $336.65 | $363.11 |
| Change today | ▲ 0.43% | ▲ 3.06% |
| Market cap | $129.88B | $129.30B |
| Return, 3 months | +0.8% | +62.5% |
| Return, year to date | +8.8% | +84.2% |
| Return, 1 year | +22.5% | +66.9% |
| P/E (TTM) | 11.9 | -626.1 |
| P/B | 1.7 | 79.8 |
| P/E percentile vs own 5y | 48th | 26th |
| Dividend yield | 1.17% | – |
| Revenue growth (YoY, latest qtr) | +7.2% | +35.9% |
| Net profit growth (YoY) | -3.9% | -237.0% |
| Gross margin | – | 72.6% |
| Operating margin | – | -8.1% |
| Net margin | 18.0% | -8.2% |
| Return on equity | 15.5% | -14.4% |
| Analyst target vs. price | +11.1% | -1.0% |
| Analyst buy share | 39% | 84% |
| RSI (14) | 47 | 66 |
| 30-day volatility | 15.4% | 69.7% |
| Max drawdown, 1 year | -9.4% | -36.8% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.